Pancreatic Cancer Research

ResearcherStony Brook UniversityNo recent work listed

Minsig Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8422-2342; OpenAlex author ID A5081077970. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients. Co-author DOI 10.1080/2162402x.2020.1773201↗
  2. Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer. Last author DOI 10.2174/1574892811666160729094415↗
  3. Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) First author DOI 10.1186/2051-1426-3-s2-p55↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lawrence G. Lum · 2 shared papers, 2015–2020 · strength 0.15
  2. Archana B. Thakur · 2 shared papers, 2015–2020 · strength 0.15
  3. Anthony Frank Shields · 2 shared papers, 2015–2020 · strength 0.15
  4. Philip A. Philip · 2 shared papers, 2015–2020 · strength 0.15
  5. Harold Bien · 1 shared paper, 2016 · strength 0.10
  6. Gerardo Guillermo Mackenzie · 1 shared paper, 2016 · strength 0.10
  7. Hemchandra Mahaseth · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.